Trident Lifeline Limited has announced a board meeting scheduled for Tuesday, May 5, 2026, to review and approve crucial financial results for the fiscal year 2026. The company has formally notified BSE Limited about this important corporate development in accordance with regulatory requirements.

Board Meeting Agenda

The board meeting will address several key items as outlined in the company's official communication:

Regulatory Compliance

The meeting notification has been issued pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory framework mandates listed companies to provide advance notice of board meetings where financial results will be considered.

Trading Window Restrictions

In compliance with insider trading prevention measures, Trident Lifeline Limited has implemented specific trading restrictions:

• Closure Date: Trading window closed from April 1, 2026
• Reopening: 48 hours after results are made public on May 5, 2026
• Regulatory Basis: SEBI (Prohibition of Insider Trading) Regulations, 2015
• Internal Framework: Company's Code of Conduct

The trading window closure was communicated through the company's letter dated March 31, 2026, ensuring all stakeholders were adequately informed about the restrictions.

Company Information

Traident Lifeline Limited, formerly known as Trident Lifeline Private Limited, operates under CIN L51909GJ2014PLC078227. The company is listed on BSE with Stock ID TLL and maintains its registered office in Surat, Gujarat. The notification was signed by Company Secretary and Compliance Officer Nikita Sharma on April 29, 2026.

Trident Lifeline Limited has informed the stock exchanges about a change in its subsidiary shareholding structure following a private placement transaction by Trident Mediquip Limited. The disclosure was made under Regulation 30 of SEBI (LODR) Regulations, 2015 on April 17, 2026.

Shareholding Change Details

The company's stake in its subsidiary Trident Mediquip Limited has been reduced due to the private placement of equity shares to other shareholders. The shareholding change reflects a dilution in the parent company's ownership percentage.

About Trident Mediquip Limited

Trident Mediquip Limited (CIN: U33309GJ2019PLC110421) is a subsidiary company incorporated under the Companies Act, 2013, with its registered office in Surat, Gujarat. The company operates in the pharmaceuticals and chemical industry.

Historical Performance

The subsidiary has shown varying performance over the past three years in terms of turnover:

Related Party Transaction

The transaction qualifies as a related party transaction since Trident Mediquip Limited is a subsidiary of Trident Lifeline Limited. Several promoter group members, including Mr. Amit Bhupendra Halvawala, Mr. Chetan Chandrakant Jariwala, and Mr. Hardik Jigishkumar Desai, have interests in both entities. The company has confirmed that the transaction was conducted on an arm's length basis.

Regulatory Compliance

The disclosure was made in compliance with SEBI regulations and the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. No governmental or regulatory approvals were required for this transaction, and no cash consideration or share swap was involved from the parent company's perspective.